Matt Biegler

Stock Analyst at Oppenheimer

(n/a)
# 4,351
Out of 4,711 analysts
1
Total ratings
n/a
Success rate
-53.71%
Average return
Main Sectors:
Top Industries:

Stocks Rated by Matt Biegler

OnKure Therapeutics
Oct 10, 2024
Initiates: Outperform
Price Target: $35
Current: $8.38
Upside: +317.66%